Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Astellas Pharma and Evec sign license agreement

Sep. 6, 2011

Addex Pharmaceuticals regains rights to metabotropic glutamate mGlu4 receptor PAM program

Sep. 5, 2011

Royal DSM and Sinochem establish global joint venture

Sep. 5, 2011

PTC Therapeutics and Genzyme restructure collaboration agreement for ataluren

Sep. 5, 2011

AnaptysBio completes generation of therapeutic antibodies for partner

Sep. 2, 2011

Synageva and Mitsubishi Tanabe Pharma sign research and development partnership

Sep. 2, 2011

Chugai in-licenses Japanese rights to two monoclonal antibodies

Sep. 2, 2011

STADA and Gedeon Richter sign agreement for rituximab and trastuzumab biosimilars

Sep. 2, 2011

Kissei obtains Japanese rights to DNA topoisomerase 2 inhibitor for anthracycline extravasation

Sep. 1, 2011

Anacor and MMV extend development agreement for malaria drug

Sep. 1, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...